ACM Research Tops Preliminary Q3 Revenue, Lifts FY2026 Outlook to $1.24B-$1.28B
ACMR sits 52% above its 52-week low of $28.46.
Summary
ACM Research reported Q3 2026 revenue of $367.7M, above its own preliminary range, and raised FY2026 revenue guidance to $1.24B-$1.28B. GAAP EPS of $0.02 was dragged down by a $39.1M non-cash investment markdown; non-GAAP diluted EPS was $0.55.
Key Events · Earnings and Guidance · ACMR
-
Q3 Revenue Tops Preliminary Range
Revenue of $367.7M rose 36.6% year over year, clearing the $360M-$365M range pre-announced on October 28, 2026.
-
FY2026 Guidance Raised Sharply
Full-year revenue outlook lifted to $1.24B-$1.28B (38%-42% growth) from $1.125B-$1.175B, implying roughly $115M more at the midpoint.
-
GAAP EPS Hit by Non-Cash Markdown
A $39.1M unrealized loss on short-term investments pushed GAAP diluted EPS down to $0.02 from $0.52; non-GAAP diluted EPS rose to $0.55 from $0.41.
-
Gross Margin Below Target Range
At 41.5% versus 42.0% a year ago, gross margin sits under the company's 42%-48% long-term model, with mix and currency cited as swing factors.
Analysis · ACMR · Technology
The headline number that resets expectations is the raised outlook: full-year revenue guidance moved to $1.24B-$1.28B from $1.125B-$1.175B, roughly $115M more at the midpoint. Third-quarter revenue of $367.7M also cleared the $360M-$365M range management pre-announced on October 28. GAAP results look ugly at first glance — $0.02 diluted EPS versus $0.52 a year ago — but the drag is a $39.1M non-cash unrealized loss on ACM Shanghai's short-term investment portfolio, not an operating problem. Non-GAAP diluted EPS rose to $0.55 from $0.41, and operating income nearly doubled to $55.5M. The real soft spot is gross margin at 41.5%, below the 42%-48% target range, while cash slipped to $1.28B from $1.36B in the quarter.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACMR was trading at $43.25 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $28.46 to $127.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.